Tenaya Therapeutics Inc
TNYA
Market Cap$139.63M
Close$
$-0.11
126.5% downside
Current Fair Value
126.5% downsideOvervalued by 126.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $139.63 Million |
|---|---|
| Enterprise Value | $149.27 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.68 |
| Beta | 2.36 |
| Outstanding Shares | 85,706,501 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.26 |
|---|---|
| PEG | 10.44 |
| Price to Sales | - |
| Price to Book Ratio | 0.41 |
| Enterprise Value to Revenue | 8.45 |
| Enterprise Value to EBIT | -1.22 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.15 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Tenaya Therapeutics Inc
2,021 employees